Is Buying Mettrum Health Corp Here a Winning Strategy?

 Is Buying Mettrum Health Corp Here a Winning Strategy?

The stock of Mettrum Health Corp (CVE:MT) is a huge mover today! About 89,866 shares traded hands. Mettrum Health Corp (CVE:MT) has risen 6.00% since October 4, 2016 and is uptrending. It has outperformed by 4.79% the S&P500.
The move comes after 9 months positive chart setup for the $192.49 million company. It was reported on Nov, 3 by Barchart.com. We have $8.16 PT which if reached, will make CVE:MT worth $202.11M more.

More notable recent Mettrum Health Corp (CVE:MT) news were published by: Reuters.com which released: “BRIEF-Mettrum Health Corp says all licenses at Bowmanville facilities rene…” on November 02, 2016, also Investingnews.com with their article: “Mettrum Health” published on June 06, 2016, Reuters.com published: “BRIEF-Mettrum Health Q1 loss per share $0.03” on November 16, 2014. More interesting news about Mettrum Health Corp (CVE:MT) were released by: Marketwired.com and their article: “Mettrum Health Corp. Announces Full Exercise of Over-Allotment Option” published on September 07, 2016 as well as Marketwired.com‘s news article titled: “Mettrum Health Corp. Responds to Health Canada’s Proposed Access to Cannabis …” with publication date: August 11, 2016.

Mettrum Health Corp. is a producer of medical cannabis. The company has a market cap of $192.49 million. The Firm is also a licensed producer and distributer of industrial cannabis (hemp) products, including Mettrum’s functional food line, Mettrum Originals. It currently has negative earnings. It has a production capacity of over 12,000 kilograms of medical cannabis per year.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment